Review

Published on 15 Dec 2022

Modulators of radiation-induced cardiopulmonary toxicities for non-small cell lung cancer: Integrated cytokines, single nucleotide variants, and HBP systems imaging

in Thoracic Oncology

Yuki Mukai-Sasaki
Zhongxing Liao
David Yang
Tomio Inoue

Frontiers in Oncology

doi 10.3389/fonc.2022.984364

2,931 views

Original Research

Published on 15 Dec 2022

Whole exome sequencing in Chinese mucinous pulmonary adenocarcinoma uncovers specific genetic variations different from lung adenocarcinoma

in Thoracic Oncology

Chenyue Zhang
Kai Wang
Wenjie Liu
Jiamao Lin
Zhenxiang Li
Hui Wang
Chenglong Zhao
Yanhua Chen
Shuangxiu Wu
Airong Yang

Frontiers in Oncology

doi 10.3389/fonc.2022.1054845

1,861 views
1 citation

Clinical Trial

Published on 15 Dec 2022

Study protocol of an open-label prospective phase II umbrella study of precise neoadjuvant therapy for patients with stage II-IIIB resectable non-small cell lung cancer (PURPOSE)

in Thoracic Oncology

Yiyang Wang
Haoran Zhai
Jiaming Wang
Teng Mao
Chunyu Ji
Feichao Bao
Zhitao Gu
Wentao Fang

Frontiers in Oncology

doi 10.3389/fonc.2022.1052774

2,745 views
1 citation

Original Research

Published on 15 Dec 2022

Investigation of M2 macrophage-related gene affecting patients prognosis and drug sensitivity in non-small cell lung cancer: Evidence from bioinformatic and experiments

in Thoracic Oncology

Zhen Zeng
Jiachen Yu
Zhuo Yang
Kangming Du
Yuewei Chen
Lei Zhou

Frontiers in Oncology

doi 10.3389/fonc.2022.1096449

2,612 views
8 citations

Correction

Published on 15 Dec 2022

Corrigendum: Immune cell-lipoprotein imbalance as a marker for early diagnosis of non-small cell lung cancer metastasis

in Thoracic Oncology

Wei Zhang
Weiwei Wang
Junlu Wu
Jiale Tian
Wenhui Yan
Yi Yuan
Yiwen Yao
Anquan Shang
Wenqiang Quan

Frontiers in Oncology

doi 10.3389/fonc.2022.1118042

1,089 views

Case Report

Published on 15 Dec 2022

Case report: Liquid biopsy, the sooner the better?

in Thoracic Oncology

Quentin Dominique Thomas
Julien Colard-Thomas
Delphine Delansay
Fanny Leenhardt
Jerome Solassol
Julie A. Vendrell
Xavier Quantin

Frontiers in Oncology

doi 10.3389/fonc.2022.1089108

2,104 views
2 citations

Review

Published on 14 Dec 2022

Metabolic targeting, immunotherapy and radiation in locally advanced non-small cell lung cancer: Where do we go from here?

in Thoracic Oncology

Annika Dhawan
Phillip M. Pifer
Vlad C. Sandulache
Heath D. Skinner

Frontiers in Oncology

doi 10.3389/fonc.2022.1016217

3,360 views
3 citations

Clinical Trial

Published on 14 Dec 2022

Low-dose computed tomography for lung cancer screening in Anhui, China: A randomized controlled trial

in Thoracic Oncology

Feng Rong
Rui Shi
Lili Hu
Ran Chen
Daoyue Wang
Xiazhi Lv
Yong Zhao
Wei Huang
Yang Yang
Hongyang Zhou

Frontiers in Oncology

doi 10.3389/fonc.2022.1059999

1,909 views
2 citations

Case Report

Published on 14 Dec 2022

Case Report: Bronchial artery embolization and chemoradiotherapy for central squamous cell lung carcinoma with rapid regression

in Thoracic Oncology

Siqi Zhou
Jianxin Zhang
Xue Meng
Yingtao Meng
Xiao Han

Frontiers in Oncology

doi 10.3389/fonc.2022.1026087

1,358 views

Original Research

Published on 14 Dec 2022

Next-generation sequencing of homologous recombination genes could predict efficacy of platinum-based chemotherapy in non-small cell lung cancer

in Thoracic Oncology

Linlin Zhang
Shasha Guan
Fanlu Meng
Lin Teng
Diansheng Zhong

Frontiers in Oncology

doi 10.3389/fonc.2022.1035808

2,357 views
4 citations

Systematic Review

Published on 14 Dec 2022

Current status and challenges of immunotherapy in ALK rearranged NSCLC

in Thoracic Oncology

Rongbin Qi
Yingying Yu
Mo Shen
Dongqing Lv
Susu He

Frontiers in Oncology

doi 10.3389/fonc.2022.1016869

2,722 views
2 citations

Correction

Published on 13 Dec 2022

Corrigendum: Serum cytokine levels for predicting immune-related adverse events and the clinical response in lung cancer treated with immunotherapy

in Thoracic Oncology

Ni Zhao
Ye Yi
Wen Cao
Xiao Fu
Nan Mei
Chunli Li

Frontiers in Oncology

doi 10.3389/fonc.2022.1069999

966 views
2 citations

Original Research

Published on 13 Dec 2022

Economic evaluation of first-line sugemalimab plus chemotherapy for metastatic non-small cell lung cancer in China

in Thoracic Oncology

Hao Wang
Li Liao
Yuan Xu
Yunchun Long
Ye Wang
Yujie Zhou

Frontiers in Oncology

doi 10.3389/fonc.2022.1081750

2,122 views
1 citation

Correction

Published on 13 Dec 2022

Corrigendum: Long non-coding RNA-TMPO-AS1 as ceRNA binding to let-7c-5p upregulates STRIP2 expression and predicts poor prognosis in lung adenocarcinoma

in Thoracic Oncology

Juan Wang
Yixiao Yuan
Lin Tang
Haoqing Zhai
Dahang Zhang
Lincan Duan
Xiulin Jiang
Chen Li

Frontiers in Oncology

doi 10.3389/fonc.2022.1109637

1,137 views
7 citations

Editorial

Published on 12 Dec 2022

Editorial: Long non-coding RNAs in lung cancer

in Thoracic Oncology

Umberto Malapelle
Giulia Veronesi

Frontiers in Oncology

doi 10.3389/fonc.2022.1100061

898 views

Review

Published on 08 Dec 2022

The natural growth history of persistent pulmonary subsolid nodules: Radiology, genetics, and clinical management

in Thoracic Oncology

Zhedong Zhang
Lixin Zhou
Fan Yang
Xiao Li

Frontiers in Oncology

doi 10.3389/fonc.2022.1011712

4,388 views
2 citations

Navigation group

Articles

Modulators of radiation-induced cardiopulmonary toxicities for non-small cell lung cancer: Integrated cytokines, single nucleotide variants, and HBP systems imaging

Whole exome sequencing in Chinese mucinous pulmonary adenocarcinoma uncovers specific genetic variations different from lung adenocarcinoma

Study protocol of an open-label prospective phase II umbrella study of precise neoadjuvant therapy for patients with stage II-IIIB resectable non-small cell lung cancer (PURPOSE)

Investigation of M2 macrophage-related gene affecting patients prognosis and drug sensitivity in non-small cell lung cancer: Evidence from bioinformatic and experiments

Corrigendum: Immune cell-lipoprotein imbalance as a marker for early diagnosis of non-small cell lung cancer metastasis

Case report: Liquid biopsy, the sooner the better?

Metabolic targeting, immunotherapy and radiation in locally advanced non-small cell lung cancer: Where do we go from here?

Low-dose computed tomography for lung cancer screening in Anhui, China: A randomized controlled trial

Case Report: Bronchial artery embolization and chemoradiotherapy for central squamous cell lung carcinoma with rapid regression

Next-generation sequencing of homologous recombination genes could predict efficacy of platinum-based chemotherapy in non-small cell lung cancer

Current status and challenges of immunotherapy in ALK rearranged NSCLC

Corrigendum: Serum cytokine levels for predicting immune-related adverse events and the clinical response in lung cancer treated with immunotherapy

Economic evaluation of first-line sugemalimab plus chemotherapy for metastatic non-small cell lung cancer in China

Corrigendum: Long non-coding RNA-TMPO-AS1 as ceRNA binding to let-7c-5p upregulates STRIP2 expression and predicts poor prognosis in lung adenocarcinoma

Editorial: Long non-coding RNAs in lung cancer

The natural growth history of persistent pulmonary subsolid nodules: Radiology, genetics, and clinical management